Medical Device and Diagnostics
News & Jobs
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile


The Medicines Company 

8 Sylvan Way

Parsippany  New Jersey  07054  U.S.A.
Phone: 973-290-6000 Fax: 973-656-9898


The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infectious disease care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland.

 Key Statistics

Ownership: Public

Web Site: The Medicines Company
Employees: 500+
Symbol: MDCO


UCB, Inc.  Contract manufacturing of Bivalirudin peptide active ingredient

 Company News
The Medicines Company (MDCO) Announces Presentation Of Investigational Hemostatic Agent RAPLIXA™ (Fibrin Sealant) Phase 3 FINISH-3 Trial Results At The 2014 Clinical Conference Of American College of Surgeons 10/29/2014 10:38:44 AM
Alnylam Pharmaceuticals (ALNY) And The Medicines Company (MDCO) Announce Filing Of A Clinical Trial Application To Initiate A Phase 1 Study For ALN-PCSsc, An Investigational, Subcutaneously Administered RNAi Therapeutic Targeting PCSK9 For The Treatment Of Hypercholesterolemia 10/28/2014 10:31:11 AM
The Medicines Company (MDCO) Wins Favorable Judgment In Angiomax® (Bivalirudin) Patent Litigation 10/28/2014 10:21:38 AM
The Medicines Company (MDCO) Announces Participation In 2014 American College Of Emergency Physicians Scientific Assembly 10/27/2014 8:51:08 AM
The Medicines Company (MDCO) Reports Third Quarter And First Nine Months 2014 Results 10/22/2014 12:42:17 PM
The Medicines Company (MDCO) To Announce Third Quarter 2014 Financial Results On Wednesday, October 22, 2014 10/9/2014 10:52:24 AM
The Medicines Company (MDCO) Infectious Disease Portfolio Data To Be Presented At ID Week 2014 10/7/2014 10:26:01 AM
The Medicines Company (MDCO) To Webcast Infectious Disease Care Investor & Analyst Day On September 24 9/24/2014 8:59:52 AM
The Medicines Company (MDCO) To Review ORBACTIV™ (Oritavancin) Launch Readiness On Tuesday, September 16, 2014 9/12/2014 10:52:41 AM
The Medicines Company (MDCO) To Present New Data From Its Infectious Disease Portfolio At The 54th Interscience Conference On Antimicrobial Agents And Chemotherapy (ICAAC) 8/28/2014 1:03:14 PM